Market cap
$129 Mln
Market cap
$129 Mln
Revenue (TTM)
$14 Mln
P/E Ratio
--
P/B Ratio
3.1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.8 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
-0.7
Debt to Equity
0
Book Value
$0.5
EPS
$-0.4
Face value
--
Shares outstanding
83,464,909
CFO
$-201.23 Mln
EBITDA
$-227.09 Mln
Net Profit
$-223.67 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Hyperfine Inc (HYPR)
| 31.2 | 3.6 | 7.1 | 84.6 | -2.8 | -33.7 | -- |
|
BSE Sensex
| -6.4 | 6.4 | -3.5 | 0.9 | 10.0 | 10.7 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Hyperfine Inc (HYPR)
| 11.3 | -21.3 | 33.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Hyperfine Inc (HYPR)
|
1.3 | 129.1 | 13.6 | -35.6 | -286.2 | -79 | -- | 3.1 |
| 6.7 | 148.5 | 4.0 | -1.5 | 0.0 | -- | -- | 0.0 | |
| 11.8 | 579.5 | 335.4 | 106.8 | 45.8 | 38.6 | 5.5 | 1.8 | |
| 10.0 | 12,842.1 | 2,870.2 | 78.8 | 19.3 | 3.6 | 82.3 | 2.5 | |
| 19.9 | 6,264.6 | 319.0 | -288.6 | 1.2 | -- | -- | 0.0 | |
| 10.8 | 313.6 | 192.2 | -1.5 | 0.0 | -0.6 | -- | 1.3 | |
| 12.1 | 3,612.8 | 2,795.0 | -246.7 | 0.6 | 21.3 | -- | 1.4 | |
| 82.7 | 9,754.2 | 2,297.4 | 715.3 | 35.8 | 30.4 | 14.2 | 3.9 | |
| 64.8 | 38,045.8 | 2,390.2 | -10.9 | -2.3 | 8.6 | -- | 12.0 | |
| 15.2 | 295.2 | 46.0 | -71.4 | -119.5 | -0.4 | -- | 7.7 |
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than... conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut. Read more
Executive Chairman
Mr. R. Scott Huennekens CPA, M.B.A.
Executive Chairman
Mr. R. Scott Huennekens CPA, M.B.A.
Headquarters
Guilford, CT
Website
The share price of Hyperfine Inc (HYPR) is $1.29 (NASDAQ) as of 21-Apr-2026 11:29 EDT. Hyperfine Inc (HYPR) has given a return of -2.82% in the last 3 years.
Since, TTM earnings of Hyperfine Inc (HYPR) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-2.26
|
1.96
|
|
2024
|
-1.56
|
1.29
|
|
2023
|
-1.80
|
0.94
|
|
2022
|
-0.80
|
0.48
|
|
2021
|
-0.45
|
0.16
|
The 52-week high and low of Hyperfine Inc (HYPR) are Rs 2.22 and Rs 0.53 as of 21-Apr-2026.
Hyperfine Inc (HYPR) has a market capitalisation of $ 129 Mln as on 17-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Hyperfine Inc (HYPR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.